|
2025 Journal Article Immune signatures across different stages of cutaneous squamous cell carcinomaFavot-Laforge, Laure, Muzotte, Elodie, Mahfouf, Walid, Rambert, Jerome, Cario, Muriel, Moisan, François, Dousset, Lea and Rezvani, Hamid-Reza (2025). Immune signatures across different stages of cutaneous squamous cell carcinoma. Journal of Dermatological Science. doi: 10.1016/j.jdermsci.2025.03.002 |
|
2025 Journal Article Energy metabolism rewiring following acute UVB irradiation is largely dependent on nuclear DNA damageDousset, Léa, Mahfouf, Walid, Younes, Hadi, Fatrouni, Hala, Faucheux, Corinne, Muzotte, Elodie, Khalife, Ferial, Rossignol, Rodrigue, Moisan, François, Cario, Muriel, Claverol, Stéphane, Favot-Laforge, Laure, Nieminen, Anni I., Vainio, Seppo, Ali, Nsrein and Rezvani, Hamid-Reza (2025). Energy metabolism rewiring following acute UVB irradiation is largely dependent on nuclear DNA damage. Free Radical Biology and Medicine, 227, 459-471. doi: 10.1016/j.freeradbiomed.2024.12.030 |
|
2024 Journal Article A new frontier in drug discovery for skin cancer through electronic medical recordsDousset, Lea and Khosrotehrani, Kiarash (2024). A new frontier in drug discovery for skin cancer through electronic medical records. British Journal of Dermatology, 192 (4) ljae489, 570-571. doi: 10.1093/bjd/ljae489 |
|
2024 Journal Article Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipientsDousset, Lea, Chambers, Daniel C., Webster, Angela, Isbel, Nicole, Campbell, Scott, Duarte, Carla, Collins, Louisa, Damian, Diona, Tseng, Anne, Karlsen, Emma, Ilinsky, Olga Victoria, Brown, Susan, Schaider, Helmut, Soyer, H. Peter, Ospino, Daniel Ariza, Hogarth, Sam, Chong, Alvin H., Mar, Victoria, McKenzie, Scott, Gin, Douglas, Fernandez-Penas, Pablo, Kern, Johannes S., Loewe, Katja, Roy, Edwige, Herschtal, Alan and Khosrotehrani, Kiarash (2024). Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients. Trials, 25 (1) 789. doi: 10.1186/s13063-024-08619-3 |
|
2024 Journal Article Tyrosine kinase inhibitors in cancers: treatment optimization – part IIFerrer, Florent, Tetu, Pauline, Dousset, Léa, Lebbe, Céleste, Ciccolini, Joseph, Combarel, David, Meyer, Nicolas, Paci, Angelo and Bouchet, Stéphane (2024). Tyrosine kinase inhibitors in cancers: treatment optimization – part II. Critical Reviews in Oncology/Hematology, 200 104385, 1-12. doi: 10.1016/j.critrevonc.2024.104385 |
|
2024 Journal Article Tyrosine Kinase Inhibitors in Cancers: treatment optimization – Part ICombarel, David, Dousset, Léa, Bouchet, Stéphane, Ferrer, Florent, Tetu, Pauline, Lebbe, Céleste, Ciccolini, Joseph, Meyer, Nicolas and Paci, Angelo (2024). Tyrosine Kinase Inhibitors in Cancers: treatment optimization – Part I. Critical Reviews in Oncology/Hematology, 199 104384, 1-16. doi: 10.1016/j.critrevonc.2024.104384 |
|
2024 Journal Article Improved survival over time with immunotherapy in locally advanced and metastatic cutaneous squamous cell carcinomasSchneider, Sophie, Ferte, Thomas, Ducharme, Océane, Dousset, Léa, Prey, Sorilla, Dutriaux, Caroline, Gerard, Emilie, Beylot-Barry, Marie and Pham-Ledard, Anne (2024). Improved survival over time with immunotherapy in locally advanced and metastatic cutaneous squamous cell carcinomas. Journal of Cancer Research and Clinical Oncology, 150 (3) 133, 1-10. doi: 10.1007/s00432-023-05593-2 |
|
2023 Journal Article Giant syringocystadenocarcinoma papilliferum with conjunctival recurrence: Possible Schimmelpenning syndrome with postzygotic G13R HRAS and K601N BRAF signatureDupont, Aurore, Vergara, Rémi, Pacaud, Alizé, Dequidt, Laure, Dutriaux, Caroline, Saunier, Valentine, Caumont, Charline, Jullie, Marie-Laure, Taïeb, Alain, Morice-Picard, Fanny and Dousset, Léa (2023). Giant syringocystadenocarcinoma papilliferum with conjunctival recurrence: Possible Schimmelpenning syndrome with postzygotic G13R HRAS and K601N BRAF signature. Journal of the European Academy of Dermatology and Venereology, 37 (12), e1420-e1422. doi: 10.1111/jdv.19346 |
|
2023 Journal Article Assessment of liquid biopsy in primary cutaneous diffuse large B-cell lymphoma–leg typeGuicheney, Marie, Ducharme, Océane, Caumont, Charline, Gerard, Emilie, Dousset, Léa, Beylot-Barry, Marie, Merlio, Jean-Philippe, Gros, Audrey and Pham-Ledard, Anne (2023). Assessment of liquid biopsy in primary cutaneous diffuse large B-cell lymphoma–leg type. Journal of Investigative Dermatology, 143 (7), 1326-1329.e5. doi: 10.1016/j.jid.2022.12.022 |
|
2022 Journal Article Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitorsGefard-Gontier, E., Markich, R., Zysman, M., Veillon, R., Daste, A., Domblides, C., Sionneau, B., Gross-Goupil, M., Lefort, F., Prey, S., Dutriaux, C., Gerard, E., Dousset, L., Pham-Ledard, A., Beylot-Barry, M., Schaeverbeke, T. and Kostine, M. (2022). Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors. Cancer Immunology, Immunotherapy, 71 (11), 2609-2618. doi: 10.1007/s00262-022-03180-x |
|
2021 Journal Article Positive association between location of melanoma, ultraviolet signature, tumor mutational burden, and response to anti–PD-1 therapyDousset, Léa, Poizeau, Florence, Robert, Caroline, Mansard, Sandrine, Mortier, Laurent, Caumont, Charline, Routier, Émilie, Dupuy, Alain, Rouanet, Jacques, Battistella, Maxime, Greliak, Anna, Cappellen, David, Galibert, Marie-Dominique, Allayous, Clara, Lespagnol, Alexandra, Gerard, Émilie, Kerneuzet, Inès, Roy, Séverine, Dutriaux, Caroline, Merlio, Jean-Philippe, Vergier, Beatrice, Schrock, Alexa B., Lee, Jessica, Ali, Siraj M., Kammerer-Jacquet, Solène-Florence, Lebbé, Céleste, Beylot-Barry, Marie and Boussemart, Lise (2021). Positive association between location of melanoma, ultraviolet signature, tumor mutational burden, and response to anti–PD-1 therapy. JCO Precision Oncology, 5 (5), 1821-1829. doi: 10.1200/PO.21.00084 |
|
2021 Journal Article Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 therapies for melanoma: A cross-sectional studyDousset, Léa, Pacaud, Alize, Barnetche, Thomas, Kostine, Marie, Dutriaux, Caroline, Pham-Ledard, Anne, Beylot-Barry, Marie, Gérard, Emilie, Prey, Sorilla, Andreu, Nicolas, Boniface, Katia and Seneschal, Julien (2021). Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 therapies for melanoma: A cross-sectional study. JAAD International, 5, 112-120. doi: 10.1016/j.jdin.2021.09.002 |
|
2021 Journal Article Predictive Factors of Non-Response to Vismodegib in Locally Advanced Basal-Cell CarcinomaMarescassier, Hélène, Dousset, Leá, Beylot-Barry, Marie, Célérier, Philippe, Vaillant, Loïc, Bedane, Christophe, Leclère, Franck, Wierzbicka-Hainaut, Ewa and Masson Regnault, Marie (2021). Predictive Factors of Non-Response to Vismodegib in Locally Advanced Basal-Cell Carcinoma. Dermatology, 237 (6), 1023-1028. doi: 10.1159/000512889 |
|
2021 Journal Article Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse eventsKostine, Marie, Mauric, Eleonora, Tison, Alice, Barnetche, Thomas, Barre, Aurélien, Nikolski, Macha, Rouxel, Léa, Dutriaux, Caroline, Dousset, Léa, Prey, Sorilla, Beylot-Barry, Marie, Seneschal, Julien, Veillon, Rémi, Vergnenegre, Charlotte, Daste, Amaury, Domblides, Charlotte, Sionneau, Baptiste, Gross-Goupil, Marine, Ravaud, Alain, Forcade, Edouard and Schaeverbeke, Thierry (2021). Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events. European Journal of Cancer, 157, 474-484. doi: 10.1016/j.ejca.2021.08.036 |
|
2021 Journal Article Real world safety outcomes using cemiplimab for cutaneous squamous cell carcinomaValentin, Julie, Gérard, Emilie, Ferte, Thomas, Prey, Sorilla, Dousset, Léa, Dutriaux, Caroline, Beylot-Barry, Marie and Pham-Ledard, Anne (2021). Real world safety outcomes using cemiplimab for cutaneous squamous cell carcinoma. Journal of Geriatric Oncology, 12 (7), 1110-1113. doi: 10.1016/j.jgo.2021.02.026 |
|
2021 Journal Article Clinicopathologic analysis of trichoblastoma and comparison with nodular basal cell carcinomaBourlond, F., Battistella, M., Amici, J. M., Dousset, L., Vergier, B., Beylot-Barry, M. and Cribier, B. (2021). Clinicopathologic analysis of trichoblastoma and comparison with nodular basal cell carcinoma. Annales de Dermatologie et de Venereologie, 148 (3), 177-182. doi: 10.1016/j.annder.2021.03.003 |
|
2021 Journal Article Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of DermatologyGuelimi, R., Salle, R., Dousset, L., Assier, H., Fourati, S., Bhujoo, Z., Barbarot, S., Boulard, C., Cazanave, C., Colin, A., Kostrzewa, E., Lesort, C., Levy Roy, A., Lombart, F., Marco Bonnet, J., Marty, L., Monfort, J. B., Riffaud, L., Samimi, M., Tardieu, M., Sbidian, E., Wolkenstein, P., Le Cleach, L. and Beylot-Barry, M. (2021). Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of Dermatology. Journal of the European Academy of Dermatology and Venereology, 35 (9), e539-e541. doi: 10.1111/jdv.17322 |
|
2021 Journal Article Complete response in a patient with advanced melanoma following anti-PD-1 therapy is associated with a high frequency of melanoma-infiltrating CXCR3+ resident memory CD8+ T cells and multiple chemokine pathwaysDousset, L., Martins, C., Jacquemin, C., Amico, S., Schatton, T., Boniface, K. and Seneschal, J. (2021). Complete response in a patient with advanced melanoma following anti-PD-1 therapy is associated with a high frequency of melanoma-infiltrating CXCR3+ resident memory CD8+ T cells and multiple chemokine pathways. British Journal of Dermatology, 185 (3), 663-666. doi: 10.1111/bjd.20405 |
|
2021 Journal Article Clinical factors predictive for histological aggressiveness of basal cell carcinoma: A prospective study of 2274 casesAmici, J. M., Dousset, L., Battistella, M., Vergier, B., Bailly, J. Y., Cogrel, O., Gusdorf, L., Alfaro, C., Ezzedine, K., Cribier, B. and Beylot-Barry, M. (2021). Clinical factors predictive for histological aggressiveness of basal cell carcinoma: A prospective study of 2274 cases. Annales de Dermatologie et de Venereologie, 148 (1), 23-27. doi: 10.1016/j.annder.2019.10.028 |
|
2021 Journal Article Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockadeMoisan, François, Oucherif, Sandra, Kaulanjan-Checkmodine, Priscilla, Prey, Sorilla, Rousseau, Benoît, Bonneu, Marc, Claverol, Stéphane, Gontier, Etienne, Lacomme, Sabrina, Dousset, Lea, Couffinhal, Thierry, Toutain, Jerome, Loot, Maya, Cario-André, Muriel, Jullié, Marie-Laure, Léauté-Labrèze, Christine, Taieb, Alain and Rezvani, Hamid Reza (2021). Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockade. Proceedings of the National Academy of Sciences of the United States of America, 118 (7) e2018690118, 1-11. doi: 10.1073/pnas.2018690118 |
